SGEN stock forecast
Our latest prediction for Seagen Inc's stock price was made on the Nov. 15, 2023 when the stock price was at 212.07$.
In the short term (2weeks), SGEN's stock price should underperform the market by -2.26%. During that period the price should oscillate between -6.16% and +0.13%.
In the medium term (3months), SGEN's stock price should underperform the market by -9.32%. During that period the price should oscillate between -26.09% and +5.33%.
Get email alertsCreate a solid portfolio with SGEN
About Seagen Inc
seattle genetics, co-founded by clay siegall, is a biotechnology company leading the field of antibody-drug conjugates (adcs) for the treatment of cancer. our technology is designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. our lead program, adcetris® (brentuximab vedotin), is the first in a new class of adcs and, in collaboration with takeda pharmaceutical company limited, is approved in more than 55 countries. to expand on the adcetris opportunity, we are conducting a broad clinical development program to evaluate its therapeutic potential in a range of other lymphoma and non-lymphoma settings. seattle genetics is also advancing a robust pipeline of clinical-stage programs, including sgn-cd19a, sgn-cd33a, sgn-liv1a, sgn-cd70a, asg-22me, asg-15me and sea-cd40. seattle genetics has collaborations for its adc technology with a number of leading biotechnology and pharmaceutical companies, including abbvie, agensys
At the moment the company generates 140M USD in revenues.
On its last earning announcement, the company reported a loss of -4.01$ per share.
The book value per share is 8.69$
Three months stock forecastNov. 15, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 140M | - | -790M | - | -554M | -4.01 | - | - | 188M | 8.69 | - | - | - |